Table 1 Study design for the bioequivalence evaluation of Voriconazole
Groups | Number of cases | The first period | The second period |
|---|---|---|---|
4 mg/kg group | 12 | Ta | Rb |
12 | R | T | |
6 mg/kg group | 12 | T | R |
12 | R | T |
Groups | Number of cases | The first period | The second period |
|---|---|---|---|
4 mg/kg group | 12 | Ta | Rb |
12 | R | T | |
6 mg/kg group | 12 | T | R |
12 | R | T |